- Report
- June 2026
- 143 Pages
Global
From €2690EUR$2,999USD£2,300GBP
€3587EUR$3,999USD£3,067GBP
- Report
- April 2026
- 135 Pages
Global
From €2690EUR$2,999USD£2,300GBP
€3587EUR$3,999USD£3,067GBP
- Report
- March 2026
- 144 Pages
Global
From €2690EUR$2,999USD£2,300GBP
€3587EUR$3,999USD£3,067GBP
- Report
- May 2026
- 400 Pages
Global
From €4440EUR$4,949USD£3,795GBP
- Report
- October 2025
- 160 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- October 2025
- 160 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- October 2025
- 160 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- May 2026
- 150 Pages
Global
From €3543EUR$3,950USD£3,029GBP
- Report
- May 2026
- 150 Pages
Global
From €3543EUR$3,950USD£3,029GBP
- Report
- May 2026
- 156 Pages
Global
From €3543EUR$3,950USD£3,029GBP
- Report
- October 2025
- 150 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- March 2026
- 144 Pages
Global
From €3543EUR$3,950USD£3,029GBP
- Report
- October 2025
- 160 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- May 2026
- 400 Pages
Global
From €4440EUR$4,949USD£3,795GBP
- Report
- May 2026
- 400 Pages
Global
From €4440EUR$4,949USD£3,795GBP
- Report
- May 2026
- 400 Pages
Global
From €4440EUR$4,949USD£3,795GBP
- Report
- May 2026
- 400 Pages
Global
From €4440EUR$4,949USD£3,795GBP
- Report
- January 2026
- 160 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- October 2025
- 160 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- February 2026
- 95 Pages
Global
From €3500EUR$4,180USD£3,097GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more